SLC6A4 and sexual dysfunction: Indeed, vilazodone, an antidepressant drug approved as an allosteric inhibitor of SERT, has been clinically observed to reduce weight gain and also to be not associated with sexual dysfunction [39,40], which are the most common adverse effects of the conventional SSRI treatments.